A trial of proficiency of nerve conduction: Greater standardization still needed

Muscle and Nerve

Volumn 48, Issue 3, 2013, Pages 369-374

  Dyck, Peter J ^a   Albers, James W ^b   Wolfe, James ^b   Bolton, Charles F ^c   Walsh, Nancy ^c   Klein, Christopher J ^a   Zafft, Andrew J ^a   Russell, James W ^d   Thomas, Karen ^d   Davies, Jenny L ^a   Carter, Rickey E ^a   Melton, L Joseph ^a   Litchy, William J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trial; Diabetic sensorimotor polyneuropathy; Nerve conduction; Proficiency; Standard reference value

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPOUND MUSCLE ACTION POTENTIAL; DIABETES MELLITUS; HUMAN; LATENT PERIOD; MEASUREMENT ACCURACY; MEDICAL EXPERT; MOTOR NERVE CONDUCTION; MOTOR NERVE DISTAL LATENCY; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; PERONEUS NERVE; PRIORITY JOURNAL; REFERENCE VALUE; SENSORY NERVE ACTION AMPLITUDE; SENSORY NERVE DISTAL LATENCY; STANDARDIZATION; SURAL NERVE; TIBIAL NERVE;

CLINICAL TRIAL; DIABETIC SENSORIMOTOR POLYNEUROPATHY; NERVE CONDUCTION; PROFICIENCY; STANDARD REFERENCE VALUE;

ACTION POTENTIALS; DIABETES MELLITUS; ELECTRODIAGNOSIS; HUMANS; JUDGMENT; NEURAL CONDUCTION; REACTION TIME; REFERENCE STANDARDS; TIME FACTORS;

EID: 84883055454     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23765     Document Type: Article

References (30)

1. Hodes R, Larrabee MG, German W. The human electromyogram in response to nerve stimulation and the conduction velocity of motor axons. Arch Neurol Psychiatry 1948;60:340-365.
2. Dawson GD. The relative excitability and conduction velocity of sensory and motor nerve fibres in man. J Physiol 1956;131:436-451.
3. Lambert EH. Electromyography and electric stimulation of peripheral nerves and muscles. In: Clinical examinations in neurology. Philadelphia: W.B. Saunders; 1956. p 287-317.
4. Kimura J. Nerve conduction and needle electromyography. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Vol. 1. Philadelphia: Elsevier; 2005. p 899-970.
5. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-824.
6. Dyck PJ, Davies JL, Clark VM, Litchy WJ, Klein CJ, Rizza RA, et al. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care 2006;29:2282-2288.
7. Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care 2007;30:2619-2625.
8. Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized controlled trial. JAMA 2000;284:2215-2221.
9. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011;34:2054-2060.
10. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Neurology 1988;38:1161-1165.
11. Diabetic polyneuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann Neurol 1995;38:478-482.
12. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetric polyneuropathy: a definition for clinical research. Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64:199-207.
13. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285-2293.
14. Dyck PJ, Hughes RAC, O'Brien PC. Quantitating overall neuropathic symptoms, impairments, and outcomes. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier; 2005. p 1031-1052.
15. Lambert EH, Dyck PJ. Compound action potentials of sural nerve in vitro in peripheral neuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier; 2005. p 1015-1028.
16. Chaudhry V, Cornblath DR, Mellitis ED, Avila O, Freimer ML, Glass JD, et al. Inter- and intra-examiner reliability of nerve conduction measurements in normal subjects. Ann Neurol 1991;30:841-843.
17. Chaudhry V, Corse AM, Cornblath DR, Kuncl RM, Freimer ML, Griffin JW. Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve 1994;17:198-205.
18. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys Trial. Muscle Nerve 2010;42:157-164.
19. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, et al. "Unequivocally abnormal" vs. "usual" signs and symptoms for proficient diagnosis of diabetic polyneuropathy. Arch Neurol 2012;69:1609-1614.
20. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of healthy subjects (RDNS-HS). Neurology 1995;45:1115-1121.
21. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45:17-23.
22. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR, Dyck PJB. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001;24:307-310.
23. Dyck PJ, Carter RE, Litchy WJ. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve 2011;44:340-345.
24. McQuillen MP, Gorin FJ. Serial ulnar nerve conduction velocity measurements in normal subjects. J Neurol Neurosurg Psychiatry 1969;32:144-148.
25. Bleasel AF, Tuck RR. Variability of repeated nerve conduction studies. Electroencephalogr Clin Neurophysiol 1991;81:417-420.
26. Valensi P, Attali JR, Gagant S. Reproducibility of parameters for assessment of diabetic neuropathy. Diabetic Med 1993;10:933-939.
27. Husstedt IW, Evers S, Grotemeyer KH. Reproducibility of different nerve conduction velocity measurements in healthy test subjects and patients suffering from diabetic polyneuropathy. Electromyogr Clin Neurophysiol 1997;37:359-363.
28. Nasseri K, Strijers RL, Dekhuijzen LS, Buster M, Bertelsmann FW. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy. Electromyogr Clin Neurophysiol 1998;38:295-299.
29. Kohara N, Kimura J, Kaji R, Goto Y, Ishii J, Takiguchi M, et al. F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 2000;43:915-921.
30. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic neuropathies. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier; 2005. p 1951-1992.